Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,738 | 21 | 72.8% |
| Food and Beverage | $6,071 | 174 | 23.6% |
| Travel and Lodging | $786.21 | 2 | 3.1% |
| Honoraria | $150.00 | 1 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $18,581 | 26 | $0 (2024) |
| Galderma Laboratories, L.P. | $1,514 | 4 | $0 (2022) |
| Merz North America, Inc. | $1,051 | 19 | $0 (2022) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $492.02 | 6 | $0 (2022) |
| LEO Pharma Inc. | $451.62 | 20 | $0 (2021) |
| PFIZER INC. | $433.84 | 11 | $0 (2024) |
| AbbVie, Inc. | $412.34 | 11 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $381.17 | 13 | $0 (2024) |
| EPI Health, LLC | $333.70 | 3 | $0 (2020) |
| Almirall LLC | $290.22 | 4 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13,707 | 23 | Regeneron Healthcare Solutions, Inc. ($13,513) |
| 2023 | $4,948 | 9 | Regeneron Healthcare Solutions, Inc. ($4,861) |
| 2022 | $608.55 | 7 | Merz North America, Inc. ($150.00) |
| 2021 | $595.67 | 21 | Ortho Dermatologics, a division of Bausch Health US, LLC ($131.58) |
| 2020 | $427.26 | 18 | VYNE Pharmaceuticals Inc. ($136.15) |
| 2019 | $2,464 | 30 | Galderma Laboratories, L.P. ($1,349) |
| 2018 | $1,803 | 46 | EPI Health, LLC ($312.94) |
| 2017 | $1,192 | 44 | AbbVie, Inc. ($250.40) |
All Payment Transactions
198 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/30/2024 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: Inflammation & Immunology | ||||||
| 10/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $42.26 | General |
| Category: Immunology | ||||||
| 07/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $41.73 | General |
| Category: Immunology | ||||||
| 04/24/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.89 | General |
| Category: Immunology | ||||||
| 04/18/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), MENQUADFI | Food and Beverage | In-kind items and services | $28.94 | General |
| Category: Vaccines | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $6,900.00 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $575.00 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| Category: ONCOLOGY | ||||||
| 03/01/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Consulting Fee | Cash or cash equivalent | $287.50 | General |
| Category: ONCOLOGY | ||||||
| 01/03/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Dermatology | ||||||
| 09/21/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, ROTARIX | Food and Beverage | In-kind items and services | $28.14 | General |
| Category: VACCINES | ||||||
| 08/16/2023 | GlaxoSmithKline, LLC. | BEXSERO (Biological), PEDIARIX, ROTARIX | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: VACCINES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 631 | 784 | $1.2M | $250,006 |
| 2022 | 16 | 491 | 601 | $916,480 | $186,024 |
| 2021 | 21 | 956 | 1,324 | $1.1M | $262,546 |
| 2020 | 22 | 881 | 1,125 | $993,040 | $217,963 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 165 | 208 | $487,760 | $87,917 | 18.0% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 76 | 122 | $168,360 | $44,066 | 26.2% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 29 | 33 | $110,055 | $25,077 | 22.8% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 42 | 54 | $118,530 | $21,128 | 17.8% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 24 | 24 | $66,000 | $14,711 | 22.3% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 60 | 61 | $103,090 | $12,668 | 12.3% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2023 | 18 | 18 | $48,600 | $11,456 | 23.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 88 | 128 | $19,840 | $9,479 | 47.8% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 41 | 42 | $63,630 | $8,576 | 13.5% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 11 | 16 | $21,200 | $5,539 | 26.1% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 13 | 13 | $18,265 | $2,968 | 16.2% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 12 | 12 | $12,960 | $2,938 | 22.7% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 30 | 31 | $6,975 | $2,509 | 36.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 22 | 22 | $2,200 | $973.60 | 44.3% |
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2022 | 99 | 132 | $309,540 | $54,616 | 17.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2022 | 57 | 83 | $114,540 | $30,080 | 26.3% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2022 | 38 | 47 | $103,165 | $22,028 | 21.4% |
| 14041 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.1-30.0 sq cm | Office | 2022 | 16 | 18 | $60,030 | $12,964 | 21.6% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2022 | 16 | 18 | $49,500 | $11,169 | 22.6% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2022 | 39 | 41 | $69,290 | $8,679 | 12.5% |
| 14021 | Repair of wound of scalp, arms, or legs by transferring skin, 10.1-30.0 sq cm | Office | 2022 | 11 | 11 | $33,990 | $7,987 | 23.5% |
| 14040 | Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | Office | 2022 | 11 | 12 | $32,400 | $7,327 | 22.6% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2022 | 17 | 20 | $26,500 | $7,039 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 55 | 81 | $11,340 | $6,174 | 54.4% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2022 | 28 | 31 | $46,965 | $5,942 | 12.7% |
About Dr. Maritza Perez, MD
Dr. Maritza Perez, MD is a Dermatology healthcare provider based in New Canaan, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831140730.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Maritza Perez, MD has received a total of $25,745 in payments from pharmaceutical and medical device companies, with $13,707 received in 2024. These payments were reported across 198 transactions from 33 companies. The most common payment nature is "Consulting Fee" ($18,738).
As a Medicare-enrolled provider, Perez has provided services to 2,959 Medicare beneficiaries, totaling 3,834 services with total Medicare billing of $916,539. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location New Canaan, CT
- Active Since 05/15/2006
- Last Updated 09/29/2022
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1831140730
Products in Payments
- LIBTAYO (Biological) $18,531
- SOOLANTRA (Drug) $1,349
- XEOMIN (Biological) $719.88
- EUCRISA (Drug) $405.00
- COSENTYX (Biological) $357.82
- Humira (Biological) $316.12
- Bensal HP (Drug) $312.94
- DUOBRII (Drug) $220.93
- ENSTILAR (Drug) $216.60
- PICATO (Drug) $201.13
- BEXSERO (Biological) $192.96
- TREMFYA (Drug) $148.16
- DUPIXENT (Biological) $145.79
- AMZEEQ (Drug) $136.15
- DORYX (Drug) $134.00
- Xeomin (Biological) $132.10
- SILIQ (Drug) $112.38
- TALTZ (Drug) $84.65
- Erivedge (Biological) $82.12
- Impoyz (Drug) $81.97
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.